Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 May 2022 for Cue Biopharma, Inc., €98k.
Filing timeline
BuySaleFrank Morich
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Frank Morich: trading record in brief
One trade, one date: on 31 May 2022, Frank Morich disclosed an open-market purchase of €98k in Cue Biopharma, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Frank Morich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 28,000 shares@ US$3.75100.0% of flowCommon StockSEC:0001209191-22-032800:0Canonical exit: 25 Aug 2022 (T+90)
1 of 1 declaration
